Brevan Howard Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,333	Closed	-$198K	–	1091
2024 Q1	$198K	Sell	11,333 -1,058	-9%	-$18.5K	﹤0.01%	760
2023 Q4	$117K	Buy	+12,391	New	+$117K	﹤0.01%	891